Open AccessTenofovir-based PrEP for COVID-19: an untapped opportunity?
Author(s) -
Colette Dejong,
Matthew A Spinelli,
Hideaki Okochi,
Monica Gandhi
Publication year - 2021
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002877
Subject(s) - emtricitabine , medicine , tenofovir alafenamide , population , efavirenz , tenofovir , pandemic , confidence interval , pre exposure prophylaxis , confounding , covid-19 , immunology , men who have sex with men , human immunodeficiency virus (hiv) , disease , viral load , antiretroviral therapy , infectious disease (medical specialty) , environmental health , syphilis